Early Virologic Failure in HIV-Coinfected Hepatitis C Patients Treated With the Peginterferon-Ribavirin Combination
- 1 May 2007
- journal article
- letter
- Published by Wolters Kluwer Health in JAIDS Journal of Acquired Immune Deficiency Syndromes
- Vol. 45 (1) , 123-125
- https://doi.org/10.1097/qai.0b013e318040b2b6
Abstract
No abstract availableThis publication has 6 references indexed in Scilit:
- Pharmacokinetics, pharmacodynamics, and hepatitis C viral kinetics during antiviral therapy: The null responderJournal of Medical Virology, 2006
- Early Virologic Nonresponse to Tenofovir, Abacavir, and Lamivudine in HIV‐Infected Antiretroviral‐Naive SubjectsThe Journal of Infectious Diseases, 2005
- Predictive factors of virological non‐response to interferon–ribavirin combination therapy for patients infected with hepatitis C virus of genotype1b and high viral loadJournal of Medical Virology, 2005
- Intracellular Pharmacokinetics of Tenofovir Diphosphate, Carbovir Triphosphate, and Lamivudine Triphosphate in Patients Receiving Triple-Nucleoside RegimensJAIDS Journal of Acquired Immune Deficiency Syndromes, 2005
- Pegylated Interferon Alfa-2b vs Standard Interferon Alfa-2b, Plus Ribavirin, for Chronic Hepatitis C in HIV-Infected PatientsA Randomized Controlled TrialJAMA, 2004
- Peginterferon Alfa-2a plus Ribavirin for Chronic Hepatitis C Virus Infection in HIV-Infected PatientsNew England Journal of Medicine, 2004